Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

Sponsor
Incyte Corporation (Industry)
Overall Status
Completed
CT.gov ID
NCT02252159
Collaborator
(none)
2,544
266
60.1
9.6
0.2

Study Details

Study Description

Brief Summary

This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients >18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the United States who will be enrolled over a 12-month period and observed for 36 months from the date the last patient is enrolled.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2544 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices
    Actual Study Start Date :
    Jul 31, 2014
    Actual Primary Completion Date :
    Aug 3, 2019
    Actual Study Completion Date :
    Aug 3, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Cohort A

    Patients with clinically overt PV (and not exhibiting any of the characteristics listed for Cohort B), managed with: Watchful waiting (with or without aspirin)*, or Phlebotomy (PHL) alone (with or without aspirin)* - or HU alone (without concomitant PHL, with or without aspirin). (*Unless patient has a history of intolerance or clinical resistance/ refractoriness to hydroxyurea [HU] (as assessed by the treating physician) - in which case, s/he belongs to Cohort B)

    Cohort B

    Patients with clinically overt PV, with one or more of the following disease characteristics: Treatment with HU and PHL in combination or Treatment with any agent other than HU or aspirin (e.g., recombinant interferon (IFN) or pegylated IFN preparations, busulfan, anagrelide) or A history of thrombosis (venous or arterial) or A history of intolerance or clinical resistance/ refractoriness to HU (as assessed by the treating physician) or Presence of documented splenomegaly (clinically assessed by palpation) or Presence of one or more of the following uncontrolled symptoms related to PV despite therapy (Symptoms deemed uncontrolled as per physician's judgment) Tiredness Difficulty sleeping Itching Muscle aches and/or bone pain Night sweats Sweats while awake Other

    Outcome Measures

    Primary Outcome Measures

    1. Description of patterns of the disease Polycythemia Vera (PV), and associations of such patterns with patients' exposures or treatments [Every 3 months for approximately 36 months]

    2. Incidence (frequency) of disease progression [Every 3 months for approximately 36 months]

    3. Incidence (frequency) of healthcare resources utilization [Every 3 months for approximately 36 months]

      Healthcare resources were defined as a. Medical visits (including Office visits, ER visits, and hospitalizations), b. phlebotomy (PHL) procedures and c. prescriptions (including PV-related prescriptions, PV-related over-the-counter (OTC) medications, and prescription medications for co-morbid conditions).

    4. Incidence (frequency) of complications due to PV [Every 3 months for approximately 36 months]

    5. Incidence (frequency) and description of PV-related symptoms [Every 3 months for approximately 36 months]

    Secondary Outcome Measures

    1. Incidence (frequency) of adverse events (for those patients on active therapies, including PHL) [Baseline through end of study. Approximately 36 months]

    2. Patient-reported outcomes as assessed by Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score (MPN-SAF TSS) for assessment of the severity of symptoms [Every 3 months for approximately 36 months]

      The MPN-SAF TSS is a validated 10-item instrument that efficiently assesses the prevalence and severity of PV symptoms in both clinical practice and trial settings. Higher scores indicate more severe symptoms and greater inactivity with a possible total score range of 0-100.

    3. Work Productivity and Activity Impairment Questionnaire - Specific Health Problem (WPAI-SHP) score for assessment of work productivity and activity impairment [Every 3 months for approximately 36 months]

      WPAI-SHP is a validated 6-item instrument that measures the effect of overall health and specific symptoms on productivity at work and outside of it. All outcomes are presented as a proportion, with 0% representing minimal/no impairment and 100% representing maximal impairment or productivity loss.

    4. European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) for Health Related Quality of Life (HRQoL) [Every 3 months for approximately 36 months]

    5. Caregiver burden [Every 3 months for approximately 36 months]

      The amount of health care received by a paid healthcare worker or by an unpaid caregiver

    6. Burden of phlebotomy (PHL) [Every 3 months for approximately 36 months]

      A patients self-reported assessment of burden including pain at site, difficulty and inconvenience of scheduling and cost factors.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age ≥18 years

    • Diagnosis of Polycythemia Vera (PV)

    • Willing and able to provide written informed consent

    • Willing and able to complete patient assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

    • Under the supervision of a physician for the current care of PV including but not limited to watchful waiting, acetylsalicylic acid (ASA) 81mg or greater, antithrombotic therapy, Phlebotomy (PHL), Hydroxyurea (HU), interferon (recombinant or pegylated), busulfan, anagrelide

    Exclusion Criteria:
    • Participation in an active clinical trial in which the study treatment is blinded

    • Life expectancy <6 months

    • Diagnosis of myelofibrosis (MF) [including primary MF, post-PV MF, or post-essential thrombocythemia MF (post-ET MF)]

    • Diagnosis of secondary Acute Myeloid Leukemia (AML)

    • Diagnosis of Myelodysplastic Syndrome (MDS)

    • History of or active plan to proceed to allogeneic hematopoietic stem cell transplant in next 3 months

    • Splenectomy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Green Valley Arizona United States
    2 Safford Arizona United States
    3 Scottsdale Arizona United States
    4 Tucson Arizona United States
    5 Yuma Arizona United States
    6 Jonesboro Arkansas United States
    7 Little Rock Arkansas United States
    8 North Little Rock Arkansas United States
    9 Stuttgart Arkansas United States
    10 Berkeley California United States
    11 Burbank California United States
    12 Corona California United States
    13 Fountain Valley California United States
    14 Highland California United States
    15 Laguna Hills California United States
    16 Los Alamitos California United States
    17 Oceanside California United States
    18 Orange California United States
    19 Pismo Beach California United States
    20 Rancho Mirage California United States
    21 Riverside California United States
    22 Santa Maria California United States
    23 Santa Rosa California United States
    24 Tarzana California United States
    25 Torrance California United States
    26 Vallejo California United States
    27 West Hills California United States
    28 Whittier California United States
    29 Aurora Colorado United States
    30 Colorado Springs Colorado United States
    31 Fort Collins Colorado United States
    32 Pueblo Colorado United States
    33 Middletown Connecticut United States
    34 Norwich Connecticut United States
    35 Stamford Connecticut United States
    36 Washington District of Columbia United States
    37 Aventura Florida United States
    38 Boynton Beach Florida United States
    39 Deerfield Beach Florida United States
    40 Fort Lauderdale Florida United States
    41 Hialeah Florida United States
    42 Hollywood Florida United States
    43 Jacksonville Florida United States
    44 Miami Lakes Florida United States
    45 Ocala Florida United States
    46 Pembroke Pines Florida United States
    47 Pensacola Florida United States
    48 Santa Rosa Beach Florida United States
    49 Winter Haven Florida United States
    50 Atlanta Georgia United States
    51 Augusta Georgia United States
    52 Austell Georgia United States
    53 Cartersville Georgia United States
    54 Columbus Georgia United States
    55 Douglasville Georgia United States
    56 Gainesville Georgia United States
    57 Marietta Georgia United States
    58 Rome Georgia United States
    59 Savannah Georgia United States
    60 Thomasville Georgia United States
    61 Boise Idaho United States
    62 Post Falls Idaho United States
    63 Berwyn Illinois United States
    64 Chicago Illinois United States
    65 Danville Illinois United States
    66 Decatur Illinois United States
    67 Effingham Illinois United States
    68 Evanston Illinois United States
    69 Harvey Illinois United States
    70 Joliet Illinois United States
    71 Kewanee Illinois United States
    72 Macomb Illinois United States
    73 Maywood Illinois United States
    74 Morris Illinois United States
    75 New Lenox Illinois United States
    76 Normal Illinois United States
    77 Ottawa Illinois United States
    78 Park Ridge Illinois United States
    79 Pekin Illinois United States
    80 Peoria Illinois United States
    81 Peru Illinois United States
    82 Princeton Illinois United States
    83 Skokie Illinois United States
    84 Springfield Illinois United States
    85 Urbana Illinois United States
    86 Anderson Indiana United States
    87 Columbus Indiana United States
    88 Crown Point Indiana United States
    89 Fort Wayne Indiana United States
    90 Indianapolis Indiana United States
    91 Lafayette Indiana United States
    92 Marion Indiana United States
    93 Mooresville Indiana United States
    94 New Albany Indiana United States
    95 Newburgh Indiana United States
    96 Terre Haute Indiana United States
    97 Cedar Rapids Iowa United States
    98 Iowa City Iowa United States
    99 Mason City Iowa United States
    100 Sioux City Iowa United States
    101 Topeka Kansas United States
    102 Wichita Kansas United States
    103 Ashland Kentucky United States
    104 Danville Kentucky United States
    105 Hazard Kentucky United States
    106 Lexington Kentucky United States
    107 Louisville Kentucky United States
    108 Mount Sterling Kentucky United States
    109 Paducah Kentucky United States
    110 Richmond Kentucky United States
    111 Alexandria Louisiana United States
    112 Baton Rouge Louisiana United States
    113 Marrero Louisiana United States
    114 Shreveport Louisiana United States
    115 Rockport Maine United States
    116 Baltimore Maryland United States
    117 Bethesda Maryland United States
    118 Clinton Maryland United States
    119 Cumberland Maryland United States
    120 Hagerstown Maryland United States
    121 Boston Massachusetts United States
    122 Fairhaven Massachusetts United States
    123 Lawrence Massachusetts United States
    124 Pittsfield Massachusetts United States
    125 Worcester Massachusetts United States
    126 Ann Arbor Michigan United States
    127 Battle Creek Michigan United States
    128 Brighton Michigan United States
    129 Canton Michigan United States
    130 Chelsea Michigan United States
    131 Dearborn Michigan United States
    132 Detroit Michigan United States
    133 Flint Michigan United States
    134 Grand Rapids Michigan United States
    135 Jackson Michigan United States
    136 Kalamazoo Michigan United States
    137 Lansing Michigan United States
    138 Marquette Michigan United States
    139 Pontiac Michigan United States
    140 Saginaw Michigan United States
    141 Edina Minnesota United States
    142 Minneapolis Minnesota United States
    143 Saint Cloud Minnesota United States
    144 Saint Louis Park Minnesota United States
    145 Saint Paul Minnesota United States
    146 Bolivar Missouri United States
    147 Cape Girardeau Missouri United States
    148 Kansas City Missouri United States
    149 Saint Louis Missouri United States
    150 Billings Montana United States
    151 Kalispell Montana United States
    152 Henderson Nevada United States
    153 Las Vegas Nevada United States
    154 Dover New Hampshire United States
    155 Portsmouth New Hampshire United States
    156 Brick New Jersey United States
    157 East Orange New Jersey United States
    158 Edison New Jersey United States
    159 Flemington New Jersey United States
    160 Hackettstown New Jersey United States
    161 Paramus New Jersey United States
    162 Somerville New Jersey United States
    163 Sparta New Jersey United States
    164 Vineland New Jersey United States
    165 Farmington New Mexico United States
    166 Albany New York United States
    167 Binghamton New York United States
    168 Bronx New York United States
    169 Brooklyn New York United States
    170 Cooperstown New York United States
    171 Corning New York United States
    172 East Setauket New York United States
    173 Elmira New York United States
    174 Herkimer New York United States
    175 Ithaca New York United States
    176 Johnson City New York United States
    177 New York New York United States
    178 Oneonta New York United States
    179 Poughkeepsie New York United States
    180 Rochester New York United States
    181 Staten Island New York United States
    182 Utica New York United States
    183 Albemarle North Carolina United States
    184 Boone North Carolina United States
    185 Charlotte North Carolina United States
    186 Clayton North Carolina United States
    187 Durham North Carolina United States
    188 Greenville North Carolina United States
    189 Hendersonville North Carolina United States
    190 Henderson North Carolina United States
    191 Hickory North Carolina United States
    192 Lincolnton North Carolina United States
    193 Shelby North Carolina United States
    194 Smithfield North Carolina United States
    195 Winston-Salem North Carolina United States
    196 Bismarck North Dakota United States
    197 Canton Ohio United States
    198 Cincinnati Ohio United States
    199 Cleveland Ohio United States
    200 Columbus Ohio United States
    201 Dover Ohio United States
    202 Huber Heights Ohio United States
    203 Massillon Ohio United States
    204 Mount Vernon Ohio United States
    205 Oregon Ohio United States
    206 Toledo Ohio United States
    207 West Chester Ohio United States
    208 Oklahoma City Oklahoma United States
    209 Beaverton Oregon United States
    210 Corvallis Oregon United States
    211 Portland Oregon United States
    212 Salem Oregon United States
    213 Allentown Pennsylvania United States
    214 Bethlehem Pennsylvania United States
    215 Broomall Pennsylvania United States
    216 Drexel Hill Pennsylvania United States
    217 Easton Pennsylvania United States
    218 Gettysburg Pennsylvania United States
    219 Hanover Pennsylvania United States
    220 Hershey Pennsylvania United States
    221 Kittanning Pennsylvania United States
    222 Philadelphia Pennsylvania United States
    223 Quakertown Pennsylvania United States
    224 Sayre Pennsylvania United States
    225 Upland Pennsylvania United States
    226 Wellsboro Pennsylvania United States
    227 Willow Grove Pennsylvania United States
    228 York Pennsylvania United States
    229 Pawtucket Rhode Island United States
    230 Charleston South Carolina United States
    231 Hilton Head Island South Carolina United States
    232 Murrells Inlet South Carolina United States
    233 Rock Hill South Carolina United States
    234 Rapid City South Dakota United States
    235 Sioux Falls South Dakota United States
    236 Watertown South Dakota United States
    237 Germantown Tennessee United States
    238 Jackson Tennessee United States
    239 Nashville Tennessee United States
    240 Abilene Texas United States
    241 Athens Texas United States
    242 Bryan Texas United States
    243 Corpus Christi Texas United States
    244 Galveston Texas United States
    245 Houston Texas United States
    246 Jacksonville Texas United States
    247 Plano Texas United States
    248 Richardson Texas United States
    249 Tyler Texas United States
    250 Ogden Utah United States
    251 Salt Lake City Utah United States
    252 Bristol Virginia United States
    253 Chesapeake Virginia United States
    254 Falls Church Virginia United States
    255 Portsmouth Virginia United States
    256 Suffolk Virginia United States
    257 Bellingham Washington United States
    258 Everett Washington United States
    259 Puyallup Washington United States
    260 Seattle Washington United States
    261 Martinsburg West Virginia United States
    262 Green Bay Wisconsin United States
    263 Milwaukee Wisconsin United States
    264 Weston Wisconsin United States
    265 Bayamon Puerto Rico
    266 Ponce Puerto Rico

    Sponsors and Collaborators

    • Incyte Corporation

    Investigators

    • Study Director: Robyn M. Scherber, MD, MPH, Incyte Corporation

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Incyte Corporation
    ClinicalTrials.gov Identifier:
    NCT02252159
    Other Study ID Numbers:
    • INCB-MA-PV-401
    First Posted:
    Sep 30, 2014
    Last Update Posted:
    Apr 26, 2021
    Last Verified:
    Apr 1, 2021

    Study Results

    No Results Posted as of Apr 26, 2021